Didi Delists

A rough month for Chinese stocks is getting even rougher. Chinese rideshare app DiDi has announced its plan to delist from the New York Stock Exchange. 

That’s probably not surprising to those of you who have been reading our coverage of the company. DiDi’s IPO got off to an explosive start, valuing the company at $70 billion. But that didn’t last — the ‘Uber of China’ quickly became a focal point in China’s latest policy drama. A cybersecurity inquiry into the company sent shares tumbling in July, which inspired a broader market  “reset” in Chinese stocks. 

DiDi’s troubles were soon the troubles of all U.S-listed Chinese companies — Alibaba, Tencent, Pinduoduo, and many more suffered from the new policy positions of the Chinese Communist Party. The government assailed media, video games, education companies, and companies which might be in the situation of “owing something” to foreign nations (read: the U.S).

China’s positions are unlikely to change after DiDi completes its voluntary de-listing. In fact, it’s probable that the company’s de-listing might encourage other U.S-listed Chinese companies to do the same. DiDi is expected to re-list itself on Hong Kong Stock Exchange — it’s been suggested that DiDi will allow investors to swap their NYSE shares for the new Hong Kong ones when it goes public overseas.

$DIDI is down 22.8% this trading week. The stock is down 60.9% since listing.

Biotech Buyout Spree Continues

It may be the last week of the year, but many companies are rushing to get deals done before year-end. Two significant transactions in the biotech space were announced today, so let’s dive in. 👇

The first deal involves RayzeBio, which raised $358 million via an initial public offering (IPO) just three months ago. However, its time as a public company is being cut short by Bristol Myers Squibb, which is acquiring the radiopharmaceutical therapeutics company for $62.50 per share in cash. 💰

Read It

Japan’s Nippon Takes Over U.S. Steel

After months of bidding, U.S. Steel finally has a buyer. However, the auction’s winner has some parties concerned. 🤔

Japan’s Nippon Steel emerged as the top bidder for the 122-year-old steelmaker, beating out offers from Cleveland-Cliffs, ArcelorMittal, and Nucor. Its $55 per share price represents a 142% premium to where $X shares were trading before Cleveland-Cliffs’ $35-per-share offer kicked off the bidding war.

Read It

A Chip Off The Holiday News Flow

It’s a slow week in the market, but as usual, there’s some news out of the semiconductor space. Let’s take a look. 👀

First up is Israel granting Intel $3.2 billion to support the company’s biggest investment in the country. Intel will not only build a $25 billion factory that creates thousands of jobs but will also buy $16.6 billion in goods and services from Israeli suppliers over the next decade. It is anticipated that the plant will open in 2028 and operate through at least 2035. 🏭

Read It

$LUNR Reaches A “Tipping Point”

One of the top stories in the market over the last 24 hours has been Intuitive Machines’, which trades under the ticker symbol $LUNR. 📻

The space exploration company’s Nova-C cargo moon lander known as “Odysseus” became the first privately developed spacecraft to land on the lunar surface. It was also the first U.S. spacecraft to soft-land on the moon in over 50 years. 🌝

Read It